- Home
- SGMO vs SSSS Comparison
SGMO vs SSSS Comparison
Compare SGMO & SSSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMO
- SSSS
- Stock Information
- Founded
- SGMO 1995
- SSSS 2010
- Country
- SGMO United States
- SSSS United States
- Employees
- SGMO N/A
- SSSS N/A
- Industry
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- SSSS Finance: Consumer Services
- Sector
- SGMO Health Care
- SSSS Finance
- Exchange
- SGMO Nasdaq
- SSSS Nasdaq
- Market Cap
- SGMO 122.8M
- SSSS 138.2M
- IPO Year
- SGMO 2000
- SSSS N/A
- Fundamental
- Price
- SGMO $0.46
- SSSS $7.34
- Analyst Decision
- SGMO Buy
- SSSS Buy
- Analyst Count
- SGMO 6
- SSSS 2
- Target Price
- SGMO $4.50
- SSSS $8.00
- AVG Volume (30 Days)
- SGMO 4.1M
- SSSS 293.7K
- Earning Date
- SGMO 08-05-2025
- SSSS 08-06-2025
- Dividend Yield
- SGMO N/A
- SSSS N/A
- EPS Growth
- SGMO N/A
- SSSS N/A
- EPS
- SGMO N/A
- SSSS N/A
- Revenue
- SGMO $63,756,000.00
- SSSS $3,644,430.00
- Revenue This Year
- SGMO N/A
- SSSS $5,400.03
- Revenue Next Year
- SGMO N/A
- SSSS N/A
- P/E Ratio
- SGMO N/A
- SSSS N/A
- Revenue Growth
- SGMO 239.92
- SSSS N/A
- 52 Week Low
- SGMO $0.30
- SSSS $3.52
- 52 Week High
- SGMO $3.18
- SSSS $7.83
- Technical
- Relative Strength Index (RSI)
- SGMO 38.27
- SSSS 66.84
- Support Level
- SGMO $0.49
- SSSS $7.11
- Resistance Level
- SGMO $0.51
- SSSS $7.50
- Average True Range (ATR)
- SGMO 0.04
- SSSS 0.34
- MACD
- SGMO 0.01
- SSSS -0.04
- Stochastic Oscillator
- SGMO 6.25
- SSSS 69.38
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About SSSS SuRo Capital Corp.
SuRo Capital Corp is a non-diversified closed-end management investment company. The company's investment objective is to maximize its portfolio's total return, principally by seeking capital gains on its equity and equity-related investments.